Abstract
The Human Papillomavirus (HPV) Prevention and Control Board convened a meeting in Bucharest, Romania (May 2018), to discuss the role of healthcare providers (HCPs) in prevention programs, with a focus on HPV vaccination and cervical cancer screening. International and local experts discussed the role that HCPs can play to increase the uptake of HPV vaccine and screening. Experts recommended: 1) increasing HCP norms of getting vaccinated; 2) training providers to make effective recommendations; 3) making culturally appropriate materials available, in local languages; and 4) centralizing and coordinating education and information material, to direct both HCPs and the general public to the best material available.
| Original language | English |
|---|---|
| Article number | 100183 |
| Number of pages | 9 |
| Journal | Papillomavirus Research |
| Volume | 8 |
| Early online date | 6 Sept 2019 |
| DOIs | |
| Publication status | Published - 1 Dec 2019 |
Bibliographical note
Funding Information:AV University of Antwerp obtained unrestricted educational grants from GSK , Merck and SPMSD ; speakers fees from Merck were paid directly to an educational fund held by the University of Antwerp .
NTB has received research grants from and served as a paid consultant for Merck and FDA .
The HPV Prevention and Control board is supported by in kind contributions and support from the international experts involved and their institutions. To set up the activities, the secretariat obtains unrestricted grants from industry (GlaxoSmithKline Biologicals, Merck, Abbott, Sanofi Pasteur and MSD). All funds are handled according to the rules of the University of Antwerp. No remuneration for experts or speakers is provided.
Acknowledgements
We thank the session chairs and speakers for their valuable slides, presentations, and comments; and the meeting participants for their thorough and insightful discussions. The authors are grateful to Lisa Lindsay (P95) for critical review of the manuscript.
